Documentation and publications for Prevent-AD about conp-portal HOT 2 CLOSED

<style type="text/css">
	html {
	  box-sizing: border-box;
	  font-size: 18px;
	}
	*, *:before, *:after {
	  box-sizing: inherit;
	}
	h1, h2, h3, h4, h5, h6 {
		margin-top: 0;
	}
	
/*copy from here*/

	.meta-details-container h2 {
		font-size: 1rem;
	}
	.meta-details-container {
		width: 100%;
		overflow:auto;
	}
	.meta-details-row {
		display: flex;
		width: 100%;
		overflow: auto;
	}
	.meta-details-left-column {
		border-right: 1px solid #343434;
		float: left;
		padding: 10px;
		width: 20%;
		max-width: 350px;
		min-width: 200px;
		text-align: right;
		border-left: 1px solid #343434;
		border-right: 1px solid #343434;
		border-bottom: 1px solid #343434;
	}
	.meta-details-right-column {
		float: right;
		padding: 20px;
		width: 80%;
		border-right: 1px solid #343434;
		border-bottom: 1px solid #343434;
	}
	.meta-details-container ul,
	.meta-details-container ol {
		width: 100%;
		list-style-position: inside;
		margin: 0;
		padding: 0;
	}
	.meta-details-container ul li,
	.meta-details-container ol li {
		margin-bottom: 10px;
	}
	.meta-details-container p {
		display: inline-block;
		width: auto;
		margin: 0;
		padding: 0 0 20px;
	}
	a.doi-link {
		display: block;
		margin: 10px 0 20px;
	}
</style>

<div class="meta-details-container"> <!-- Container Div Start-->
	<div class="meta-details-row"> <!-- Container Div Row Start -->
		<div class="meta-details-left-column"> 
			<h2>Documentation</h2>
		</div>
		<div class="meta-details-right-column">
			<ul>
				<li>
					<a href="https://conp.ca/wp-content/uploads/2019/04/PREVENT-AD-short-description.pdf">Prevent-AD short description</a>
				</li>
				<li>
					<a href="https://conp.ca/wp-content/uploads/2019/04/MRI-protocol-for-open-science.pdf">MRI protocol for Open Science</a>
				</li>
			</ul>
		</div>
	</div><!-- Container Div Row End -->
	<div class="meta-details-row"> <!-- Container Div Row Start -->
		<div class="meta-details-left-column">
			<h2>List of Publications</h2>
		</div>
		<div class="meta-details-right-column">
			<ol>
				<li>
					Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease. Vogel JW, Vachon-Presseau E, Pichet Binette A, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P, Breitner JCS, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative and the PREVENT-AD Research Group. Brain. 2018 Apr 23.
					
					<a class="doi-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29688388">doi: 10.1093/brain/awy093.</a>
				</li>
				<li>
					Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis. Meyer PF, Savard M, Poirier J, Labonté A, Rosa-Neto P, Weitz TM, Town T, Breitner, J; Alzheimer’s Disease Neuroimaging Initiative; PREVENT-AD Research Group. J Alzheimers Dis. 2018 Apr 11.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/29660934">doi: 10.3233/JAD-170887.</a>
				</li>
				<li>
					Subjective cognitive decline is associated with altered Default Mode Network connectivity in individuals with a family history of Alzheimer’s Disease, Verfaillie SCJ, Pichet Binette A, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JC, Villeneuve S for the PREVENT-AD Research Group. Biological Psychiatry: Cognitive Neurosciences and Neuroimaging. May 2018.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/29735156">doi: 10.1016/j.bpsc.2017</a>
				</li>
				<li>
					Proximity to Parental Symptoms Onset and Amyloid-β Burden in sporadic Alzheimer disease. Villeneuve S, Vogel JW, Gonneaud J, Pichet Binette A, Rosa-Neto P, Gauthier S, Bateman RJ, Fagan AM, Morris JC, Benzinger TL, Johnson SC, Breitner JC, Poirier J, for the Prevent-AD group. JAMA Neurology. 2018 May 1.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/29482212">doi: 10.1001/jamaneurol.2017.5135.</a>
				</li>
				<li>
					Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer’s disease, Tardif CL, Devenyi G, Amaral RSC, Pelleieux S, Poirier J, Rosa-Neto P, Breitner J, Chakravarty MM; PREVENT-AD Research Group., Hum Brain Mapp. 2017 Nov 21.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/29164798">doi: 10.1002/hbm.23897</a>
				</li>
				<li>
					Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease, Tuwaig, Miranda, Savard, Mélissa, Jutras, Benoît, Judes Poirier, Louis Collins, Pedro Rosa-Neto, David Fontaine and John C.S. Breitner for the PREVENT-AD Research Group, Journal of Alzheimer's Disease, vol. 60, no. 4, pp. 1589-1600, 21 Aug 2017.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/28984583">doi: 10.3233/JAD-170545</a>
				</li>
				<li>
					Validation of a Regression Technique for Segmentation of White Matter Hyperintensities in Alzheimer's Disease. Dadar M, Pascoal TA, Manitsirikul S, Misquitta K, Fonov VS, Tartaglia MC, Breitner J, Rosa-Neto P, Carmichael OT, Decarli C, Collins DL. IEEE Trans Med Imaging. 2017 Aug;36(8):1758-1768.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/28422655">doi: 10.1109/TMI.2017.2693978</a>
				</li>
				<li>
					Odor identification as a biomarker of preclinical AD in older adults at risk. Lafaille-Magnan ME, Poirier J, Etienne P, Tremblay-Mercier J, Frenette J, Rosa-Neto P, Breitner JCS; PREVENT-AD Research Group. Neurology. 2017 Jul 25;89(4):327-335.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/28659431">doi: 10.1212/WNL.0000000000004159</a>
				</li>
				<li>
					Alzheimer’s Progression Score’: Development of a Biomarker Summary Outcome for AD Prevention Trials J.-M. Leoutsakos, A.L. Gross , R.N. Jones, M.S. Albert, J.C.S. Breitner (2016) The Journal of Prevention of Alzheimer’s Disease - JPAD© Volume 3, Number 4, 2016.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/29034223">doi: 10.14283/jpad.2016</a>
				</li>
				<li>
					Rationale and Structure for a new Center for Studies on Prevention of Alzheimer’s Disease (StoP-AD) J.C.S. Breitner, J. Poirier, P.E. Etienne1, J.M. Leoutsakos for the PREVENT-AD Research Group (2016) The Journal of Prevention of Alzheimer’s Disease - JPAD© Volume 3, Number 4, 2016.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/29199324">doi: 10.14283/jpad.2016.121.</a>
				</li>
				<li>
					Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer's disease. Orban P, Madjar C, Savard M, Dansereau C, Tam A, Das S, Evans AC, Rosa-Neto P, Breitner JC, Bellec P; PREVENT-AD Research Group. Sci Data. 2015 Oct 13;2:150043.
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/26504522">doi: 10.1038/sdata.2015.43.</a>
				</li>
				<li>
					INTREPAD: a randomized trial of naproxen to slow progress of pre-symptomatic Alzheimer’s disease, Pierre François Meyer*, MSc; Jennifer Tremblay-Mercier*, MSc; Jeannie Leoutsakos, PhD; Cécile Madjar, MSc; Marie-Élyse Lafaille-Maignan, PhD; Melissa Savard, MSc; Pedro Rosa-Neto, MD, PhD; Judes Poirier, PhD**; Pierre Etienne, MD**; John Breitner, MD, MPH** for the PREVENT-AD research group. Neurology, 2019 Apr 5 [Epub ahead of print].
					
					<a class="doi-link"  href="https://www.ncbi.nlm.nih.gov/pubmed/30952794">doi: 10.1212/WNL.0000000000007232.</a>
				</li>
			</ol>
		</div>		
	</div><!-- Container Div Row Start -->
</div><!-- Container Div End -->